Mainz Biomed N.V. - stock earnings

MYNZ Upcoming estimated earnings

Date Actual / Estimated EPS Low Revenue Actual / Estimated Revenue High Revenue
May 21, 2024 BeforeMarket - / -0.3100000000 - - / 220000 -

MYNZ Quarterly earnings

DateEarningsRevenue
2024Q1 -5.2 million USD 214761 USD
2023Q4 -5.2 million USD 214761 USD
2023Q3 -6.3 million USD 181669 USD
2023Q2 -8.3 million USD 248945 USD
2023Q1 -6.6 million USD 250104 USD
2022Q4 -2.9 million USD 144337 USD
2022Q3 -5.6 million USD 96791 USD
2022Q2 -6.9 million USD 139240 USD
2022Q1 -11.4 million USD 160037 USD
2021Q4 -3.0 million USD 144337 USD
2021Q3 -2.9 million USD 144337 USD
2021Q2 -240752 USD 417311 USD
2021Q1 -39992 USD 144337 USD
2020Q4 -146723 USD 123391 USD
2020Q3 -146723 USD 123391 USD
2020Q2 -146723 USD 123391 USD
2020Q1 -146723 USD 123391 USD
2019Q4 -239263 USD 70348 USD
2019Q3 -239263 USD 70348 USD
2019Q2 -239263 USD 70348 USD
2019Q1 -239263 USD 70348 USD

MYNZ Yearly earnings

DateEarningsRevenue
2023 -26.3 million USD 895479 USD
2022 -26.5 million USD 529877 USD
2021 -12.1 million USD 577348 USD
2020 -886177 USD 493565 USD
2019 -1.2 million USD 281393 USD

MYNZ

Price: $0.68

52 week price:
0.60
6.00

Earnings Per Share: -1.62 USD

P/E Ratio: -0.53

Exchange: NCM

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 15400

Market Capitalization: 14.1 million

Links: